News 
Market Data 
Discover
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$FOMO has started.
Anti-snoring Devices And Snoring Surgery Market Size, Share & Trends Analysis Report By Type (Oral Appliances/ Mouthpieces, Position Control Devices, Nasal Devices, Chin Straps, Tongue Stabilizing Devices), By Region, And Segment Forecasts, 2023 - 2030
The global anti-snoring devices and snoring surgery market size was estimated at USD 1.52 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2030. Increasing incidence of obesity, the launch of technologically advanced devices, preference for non-invasive treatments, the availability of minimally invasive surgeries, strategic activities by key market players, and easy availability of products through online and offline channels are key factors driving the growth of the market for anti-snoring devices and snoring surgery.
Could be setting up a sales network ???
$APYP
if you type appysleep into Google and hit search, a few days ago it was showing 3,810 links. Today is shows 4,890 links. Looks like internet presence is growing. That's over 1,000 new links in just a few days. Something up?
Pink sheets?
$APYP if you type appysleep into Google and hit search, a few days ago it was showing 3,810 links. Today is shows 4,890 links. Looks like internet presence is growing. That's over 1,000 new links in just a few days. Something up?
I can see APYP moving back to the OTCQX and at some point, maybe very soon, then back to the NYSE.
The revenue potential here is open ended and it looks like the CEO has a history of making things happen.
Yes and no.
$APYP Chart...
Post pictures too.
$APYP No tax loss selling. What does that tell you.
$APYP Chart...
Finally product is on the shelves for the public. Now we have something for sure.
$APYP AppYea Establishes U.S. Distribution and Logistics in Preparation for
Imminent Commercial Launch
AppYea Inc. (OTCQB: APYP), focusing on the development of accurate wearable
monitoring solutions to treat sleep apnea and snoring, today announced it has
completed logistics arrangements and delivery of initial inventory to commence the
commercial launch and distribution of its AppySleep product in the U.S.
The first batch of AppySleep, the Company’s revolutionary product to treat snoring
problem, was dispatched to the company's logistics warehouse in New Jersey and the
Company intends to start supplying customers in the coming days
$APYP AppYea Provides Year-End Letter to Shareholders Recapping Key Achievements and Sharing Outlook for 2024
https://www.accesswire.com/viewarticle.aspx?id=816477&lang=en
To our valued shareholders,
I am thrilled to share the remarkable strides our company has made throughout the past year. This period has undeniably marked a pivotal turning point for us, and I am excited to provide you with a comprehensive update on our progress in 2023 and our outlook for the year to come.
2023 was a transformative year, as we geared up to enter the commercial phase and begin marketing our products in both the United States and globally. We recognize the increasing demand for sleep-related products, and we're now poised to introduce an innovative product that we believe will make a significant impact on people's lives and establish ourselves as a major player in the sleep solutions market.
Our business platform is built on a portfolio of registered patents, particularly in the field of sleep and respiratory-related markets. As many are aware, our patent portfolio includes the detection of snoring, sleep apnea, sleep stages and the diagnosis of sleep quality through voice analysis, setting us apart with a distinct competitive advantage.
Technological Advancements: Our commitment to innovation has propelled us forward. Notably, we successfully revamped our mobile application, enhancing the user experience and functionality. Simultaneously, we achieved a significant milestone with the completion of our Android wristband development.
Intellectual Property Expansion: Bolstering our commitment to innovation, we expanded our approved patent portfolio. This intellectual property growth safeguards our technological advancements and positions us as a key player in the industry.
Manufacturing Success: We commenced successful manufacturing of our inaugural batch of wristbands, poised for delivery to our clients. This achievement not only demonstrates our dedication to quality but also our ability to translate conceptual designs into tangible products.
Strategic Partnerships: In our pursuit of operational excellence, we have secured a partnership with a leading US automated logistics warehouse facility. This strategic alliance streamlines our order distribution process, ensuring timely and efficient delivery to our valued customers.
E-commerce Expansion: We're delighted to reveal the successful culmination of our AppySleep brand development journey. This dynamic new brand is set to take the lead in promoting our cutting-edge AppYea products. Concurrently, we've rolled out an all-encompassing marketing strategy, highlighted by the launch of our dedicated website, AppySleep.com. Additionally, we are in the final stages of opening our store on Amazon. This move aligns with our vision to make our products easily accessible to a global audience.
Leadership Enhancement: I was honored to join the Company earlier this year, bringing a proven track record in selling medical devices in the US. My willingness to lead the team follows extensive due diligence and should serve as a testament to my confidence in AppYea's value proposition. I look forward to leveraging my personal expertise and industry relationships to accelerate our commercialization strategy.
Financial Strengthening: Recognizing the importance of a robust financial foundation, we successfully engaged with a group of investors which strategically aims to alleviate the company from the burden of its prior convertible debt and minimize dilution, setting the stage for a financially sound future and maximizing returns for shareholders.
Capital Infusion and Expanded Market Presence: We have secured additional capital to fuel our operations, marketing initiatives, and the development of future products. This financial injection empowers us to not only sustain our current momentum but also explore new opportunities and markets.
Product Expansion: As we look ahead to 2024, we anticipate the launch of our IOS app during the first half of 2024. This significant development is a testament to our unwavering dedication to providing cutting-edge solutions to our users.
Stay tuned for more exciting developments in the weeks, months and years ahead as we continue on this exciting journey to bring our innovative solutions to the forefront of the sleep industry, leveraging our cutting-edge technology and staying ahead of market trends.
We appreciate your continued support on this transformative journey as we continue to pioneer advancements in sleep technology and begin the commercial phase of our mission to bring disruptive technologies to the market, while improving the quality of life for millions.
The future of better sleep starts with us!
Thank you for your trust and partnership.
Adi Shemer, CEO
About AppYea
AppYea is a Healthtech company commercializing a breakthrough wearable technology for the treatment of snoring and developing wearable solutions to diagnose and treat sleep apnea. The company's solutions are based on its proprietary IP portfolio of AI and sensing technologies for the tracking and analysis of breathing patterns, vital-signs, and other physiological parameters during sleep, designed for greater accuracy at lower and affordable cost.
Cautionary Note Regarding Forward-Looking Statements
Statements included in this press release, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to the future performance of AppYea are subject to many factors including , but not limited to, the sufficiency or working capital and our ability to raise the capital needed to fund our development efforts, timing of product development, FDA approval/clearance of products in development, customer acceptance of our products in the market, the introduction of competitive products, the impact of any product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in the S-1 resale registration statement filed with the Securities and Exchange Commission. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. The forward-looking statements contained in this press release are made as of the date hereof, and we do not undertake any obligation to update any forward-looking statements, whether as a result of future events, new information, or otherwise.
Contact:
Crescendo Communications, LLC
Tel: (212) 671-1020
Email: APYP@Crescendo-IR.com
SOURCE: APPYEA, Inc.
$APYP 
$APYP Gap is filled or very close.
Did that gap from October 18th fill yet? tia.
$APYP SleepX wristband now accepts PayPal...
The product is out people. You can buy online.
https://sleepxapp.com/product/sleepx-wristband/
|
Followers
|
513
|
Posters
|
|
|
Posts (Today)
|
0
|
Posts (Total)
|
52608
|
|
Created
|
10/22/14
|
Type
|
Free
|
| Moderators | |||
Working today for tomorrow's future.
The Diagnostic Center Inc, is a newly formed marketing and service subsidiary of AppYea, Inc. (OTC:APYP) that empowers physician offices, clinics, hospitals, long term care facilities, healthcare groups, employers, governmental units and correctional institutions in getting comprehensive diagnostic testing results quicker. Our goal is to work with multiple diagnostic testing facilities throughout the United States and at the same time using numerous collectors to handle the samples personally therefore expediting the process.
We provide fast and accurate results. With screening results within 24 hours and full confirmation of 78 tests.
https://www.thediagnosticcenters.com/investors/
Boca Raton, FL, and Rehovot, Israel (OTC Pink: APYP) AppYea, Inc. ("AppYea" or the "Company") begun the process to acquire 100% of the outstanding shares of SleepX Ltd., a company formed under the laws of Israel ("SleepX") and Nexense Technologies USA Inc., a Delaware corporation.
Todd Violette, CEO of AppYea stated, "I have been very impressed with the SleepX management team in Israel and SleepXs products and technology. SleepX holds a portfolio of patents and products designed to prevent snoring and sleep apnea, which I believe present a unique opportunity for AppYea."
AppYea management's review of information from Research and Markets September 18, 2020 industry report, indicates the global sleep apnea device market is forecast to increase to US$9.29 billion in 2024, growing at a compounded annual growth rate of 7.94% between 2020-2024. The same report found that the fastest-growing regional market wasNorth America, with the highest incidence of obstructive sleep apnea cases, provided that Europealso represents a large available market.
"SleepX has developed a unique technology for monitoring sleep apnea. The Technology and IP are protected via international patents - sleep apnea detection and sleep phases analysis through sound wave analysis, developed in the Biomedical Department of Ben Gurion University in Beer Sheva, Israel.Based on this technology, one of the leading products SleepX offers is a unique night bracelet for the treatment of snoring using artificial Intelligence", said Bary Molchadsky, CEO of SleepX.
News LINK: https://www.otcmarkets.com/stock/APYP/news/APYP-begin-process-for-Acquisition-of-SleepX-Ltd?id=287757
Boca Raton, FL (OTC Ticker: APYP) Appyea, Inc, on January 28, 2021, announced the entry into a non-binding Letter of Intent (LOI) for the acquisition of SleepX Ltd. from Israel.
https://www.otcmarkets.com/stock/APYP/news/APYP-Update?id=290348
Patent information
https://www.sleepxclear.com/unique-technology
*******************************************************************************************************************************************************************************************************************************************************************
AppYea Holding Inc.
Cannabis Blockchain
One of our subsidiaries, will be going into the Cannabis Blockchain Business. Last year, while I was researching the cannabis industry, I identified some key business models unique to the cannabis industry that are incredibly different from those currently being promoted in the Cannabis Capital Markets. The number one principle that drives the success in the cannabis industry for long term valuation and growth is the principle to acquire the "Customer First." Therefore, building a Cannabis Blockchain for the customers and expanding delivery services that deliver cannabis to people in their homes will be the end target market. I have approved the Subsidiary of AppYea Holding Inc., and the newly formed Canadian Subsidiary will transition, focusing the business development during 2021 on building a Cannabis Blockchain Company.
I view this opportunity based upon the belief that by 2022, California's cannabis market is projected to jump to $5 billion boosted significantly by California's recreational cannabis market. The California cannabis industry's total economic impact could be nearly $10 billion.
The Environmental benefit results from creating a decentralized, encrypted database validating SOP processes as they occur during Cannabis Cultivation. The record's benefit will track the amount of pesticide used, water consumed, and soil degradation.
The Person partaking in the use of the product benefits from a cleaner and better product to enjoy. In the future, we envision the consumer being able to scan the QR code with their phone and use the Blockchain to see the record of the nutrients solution recipe or the amount of pesticide used during the cultivation and packaging process. The end customer will have a history of the Cannabis plant through all stages of the plant's life cycle to verify the final product's product outcome and authenticity.
The Government could begin using the system to be more efficient with tax collections and implementing more effective regulatory policies. We can expect that governments will finally acceptblockchainbenefits and improve critical applications improving tracking financial transactions and ensuring people's identity in the seed to the sale process.
The Cannabis Blockchain cansignificantlyimprove supply chainsby enabling faster and more cost-efficient product deliveries, enhancing product traceability,and enhancingcoordination between customers, drivers, and central locations.
I feel these targeted areas with a combination of proprietary plans will allow the Company to build out a revenue model and use the base assets being developed to potentially generate revenue within the next year. I recently traveled to the Province of Saskatchewan to view a location and meet with a local representative that owns the property for a site that could access power, internet, and host multiple servers. The vision would include developing Agricultural Data and becoming an Ag Tech Datacenter using blockchain technology.
*******************************************************************************************************************************************************************************************************************************************************************
Mr. Todd Violette serves as NEW Chairman of the Board, Chief Executive Officer of the Company. Mr. Violette brings a wealth of experience to AppYea, having spent more than 24 years evaluating and participating investment opportunities across the capital structure of North American companies with a focus on OTC companies. Mr. Violette has worked in a management capacity as a chief executive officer, affecting corporate actions and implementing policies in order to maximize shareholder value. AppYea has previously announced its participation and desire to be in the CBD and Hemp business Mr. Violette disclosed to the Board a potential conflict of interest regarding his outside participation in a project working with a team of experts building 55,000 sq. feet private hemp exaction facility in in Western Kentucky. Any opportunity resulting from this operation will first be brought to AppYea. Mr. Violette graduated of the University of Maryland College Park in 1992.
*******************************************************************************************************************************************************************************************************************************************************************
Contact Information
AppYea Inc.
1-800-674-3561 or Email info@appyea.com
1-800-674-3561 Please Phone or Text Email: info@appyea.com
Twitter Link: https://twitter.com/AppyeaInc/status/1346914866183892994
AI
